Related Experiment Video
Updated: Jul 11, 2026

07:48
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
22.7K
Rapid development of clone-specific, high-performing perfusion media from established feed supplements.
Patrick Mayrhofer1, David Reinhart1, Andreas Castan2
1Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.
Biotechnology Progress
|November 5, 2019
Summary
Developing clone-specific perfusion media for recombinant Chinese hamster ovary (CHO) cells significantly boosts biopharmaceutical production. This rapid, two-step method optimizes media blends, achieving high cell densities and space-time-yields (STYs).
Area of Science:
- Biotechnology and Biopharmaceutical Manufacturing
- Cell Culture Technology
- Process Optimization
Background:
- Perfusion cultivation of recombinant Chinese hamster ovary (CHO) cells is crucial for the biopharmaceutical industry due to enhanced space-time-yields (STYs) and reduced residence times.
- Economical bioprocesses require cultivation media that support rapid cell growth and high protein production with minimal consumption.
- Developing tailored media is essential for maximizing the efficiency of perfusion cultures.
Purpose of the Study:
- To present a straightforward and rapid two-step approach for developing clone-specific, high-performing perfusion media for recombinant CHO cells.
- To optimize media formulations by combining commercially available basal media and feed supplements using design-of-experiment (DoE).
- To achieve high cell densities and STYs in perfusion cultures.
Main Methods:
- A two-step strategy involving initial selection of feed supplements in batch cultures.
- Optimization of feed supplement mixing ratios in small-scale semicontinuous perfusion cultures.
- Statistical response surface modeling to finalize media blends, followed by verification in perfusion bioreactors.
Main Results:
- Two novel media blends were developed, enabling perfusion bioreactor runs to reach 200 × 10^6 cells/ml within two weeks.
- Achieved minimum cell-specific perfusion rates as low as 10-30 pL/cell/day.
- Obtained STYs ranging from 0.4-1.2 g/L/day, representing a 10-fold increase compared to batch cultures.
Conclusions:
- The presented two-step workflow is effective for developing high-performing perfusion media for recombinant CHO cells.
- The optimized media blends significantly enhance cell density and productivity in perfusion cultures.
- This general workflow is broadly applicable to various perfusion platforms, cell lines, and media components.
More Related Videos
Related Concept Videos
Designing Growth Media for Bioreactors
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

